[Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, HCL-benserazide, on Parkinson's disease-part I: clinical aspects (author's transl)].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples